Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Rating of “Hold” by Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned a consensus rating of “Hold” from the six analysts that are currently covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $16.25.

MD has been the topic of several research analyst reports. UBS Group upped their target price on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Jefferies Financial Group raised their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. StockNews.com downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 19th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $12.81 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $16.41. The company has a 50 day simple moving average of $14.35 and a two-hundred day simple moving average of $11.49. The company has a market capitalization of $1.10 billion, a PE ratio of -4.19, a P/E/G ratio of 2.00 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to analysts’ expectations of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Pediatrix Medical Group’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.29 earnings per share. Research analysts anticipate that Pediatrix Medical Group will post 1.26 earnings per share for the current year.

Insider Transactions at Pediatrix Medical Group

In other news, Director Mark S. Ordan sold 27,600 shares of the company’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the sale, the director now owns 138,683 shares in the company, valued at $2,128,784.05. This represents a 16.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the completion of the sale, the executive vice president now owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. This represents a 5.63 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

Institutional Trading of Pediatrix Medical Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. nVerses Capital LLC bought a new position in Pediatrix Medical Group in the 2nd quarter valued at $31,000. Quest Partners LLC grew its position in Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after buying an additional 622 shares during the period. Quarry LP grew its position in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after buying an additional 1,662 shares during the period. Canada Pension Plan Investment Board purchased a new stake in Pediatrix Medical Group during the second quarter worth about $72,000. Finally, CWM LLC raised its position in Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company’s stock worth $74,000 after acquiring an additional 3,681 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.